Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ROBERT C BAST JR and ZHEN LU.
ROBERT C BAST JR
Connection Strength
2.818
ZHEN LU
  1. The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Cell Adh Migr. 2013 Mar-Apr; 7(2):232-6.
    View in: PubMed
    Score: 0.459
  2. Tumor suppressor genes. Cancer Treat Res. 2009; 149:109-29.
    View in: PubMed
    Score: 0.346
  3. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest. 2008 Dec; 118(12):3917-29.
    View in: PubMed
    Score: 0.344
  4. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2404-13.
    View in: PubMed
    Score: 0.287
  5. Biomarkers and Strategies for Early Detection of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2504-2512.
    View in: PubMed
    Score: 0.196
  6. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer. 2011 Oct 01; 117(19):4424-38.
    View in: PubMed
    Score: 0.105
  7. Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. Cancer Res. 2011 Sep 01; 71(17):5806-17.
    View in: PubMed
    Score: 0.103
  8. Dasatinib induces autophagic cell death in human ovarian cancer. Cancer. 2010 Nov 01; 116(21):4980-90.
    View in: PubMed
    Score: 0.098
  9. SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer. Cancer Cell. 2010 Aug 09; 18(2):109-21.
    View in: PubMed
    Score: 0.097
  10. CA125/MUC16 is dispensable for mouse development and reproduction. PLoS One. 2009; 4(3):e4675.
    View in: PubMed
    Score: 0.088
  11. MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse. Differentiation. 2008 Dec; 76(10):1081-92.
    View in: PubMed
    Score: 0.084
  12. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 2008 Apr 01; 112(7):1489-502.
    View in: PubMed
    Score: 0.082
  13. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment. Gynecol Oncol. 2007 Sep; 106(3):490-7.
    View in: PubMed
    Score: 0.077
  14. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007; 174:91-100.
    View in: PubMed
    Score: 0.075
  15. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway. Cell Cycle. 2006 Aug; 5(15):1654-61.
    View in: PubMed
    Score: 0.073
  16. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol. 2006; 407:455-68.
    View in: PubMed
    Score: 0.070
  17. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma. Epigenetics. 2013 Dec; 8(12):1330-46.
    View in: PubMed
    Score: 0.030
  18. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.027
  19. A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis. J Exp Ther Oncol. 2012; 10(2):155-62.
    View in: PubMed
    Score: 0.027
  20. Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3. J Med Chem. 2011 May 26; 54(10):3549-63.
    View in: PubMed
    Score: 0.025
  21. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer. 2011 Jan 19; 11:22.
    View in: PubMed
    Score: 0.025
  22. ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins. Biosci Rep. 2009 Dec 15; 30(3):159-68.
    View in: PubMed
    Score: 0.023
  23. A novel hTERT promoter-driven E1A therapeutic for ovarian cancer. Mol Cancer Ther. 2009 Aug; 8(8):2375-82.
    View in: PubMed
    Score: 0.023
  24. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol. 2008 Aug; 110(2):196-201.
    View in: PubMed
    Score: 0.021
  25. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Cancer Res. 2005 Aug 01; 65(15):6701-10.
    View in: PubMed
    Score: 0.017
  26. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3660-6.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.